Insulet (PODD) has been quietly recalibrating after a choppy past month, with the stock down around 11% even as its year to date gain sits in the mid teens, inviting a closer look. See our latest ...

Fintel reports that on December 18, 2025, Truist Securities maintained coverage of Insulet (NasdaqGS:PODD) with a Buy recommendation. Analyst Price Forecast Suggests 31.68% Upside As of December 5, ...

Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Companies spend billions on programs that don’t pay off. Here’s how to fix that. by Michael Beer, Magnus Finnström and Derek Schrader Corporations are victims of the great training robbery. American ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...